You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 286 Tumor targeting and tissue biodistribution of RO7122290, a novel FAP-targeted 4–1BB (CD137) agonist, in patients with advanced solid tumors, using [89Zr]-RO7122290 as a PET tracer

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Clinical trials completed
286 Tumor targeting and tissue biodistribution of RO7122290, a novel FAP-targeted 4–1BB (CD137) agonist, in patients with advanced solid tumors, using [89Zr]-RO7122290 as a PET tracer

 

Online download statistics by month:

Online download statistics by month: November 2020 to November 2024

AbstractFullPdf
Nov 2020169023
Dec 202055010
Jan 202162012
Feb 202162013
Mar 202184017
Apr 202176023
May 2021706
Jun 2021009
Jul 20210010
Aug 20210010
Sep 20210012
Oct 202168025
Nov 202182026
Dec 20213609
Jan 20226006
Feb 202219013
Mar 20221007
Apr 202282016
May 20226807
Jun 20227409
Jul 20226406
Aug 202270010
Sep 20223205
Oct 20225003
Nov 202214209
Dec 20226803
Jan 20236204
Feb 202374014
Mar 202378015
Apr 202354012
May 2023216026
Jun 202364012
Jul 202354010
Aug 202382014
Sep 20232807
Oct 20234807
Nov 20233208
Dec 20234408
Jan 20242003
Feb 20243006
Mar 20246007
Apr 20242206
May 20243006
Jun 202478015
Jul 20246204
Aug 20243401
Sep 20243805
Oct 202450014
Nov 202464011
Total27640514